Cargando…
Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3′-oxime (7BIO)
BACKGROUND: The indirubin derivative 7-bromoindirubin-3′-oxime (7BIO) has already shown anticancer properties by causing cell death in some tumour cell lines and may be a new therapeutic option for treatment-resistant tumour cells. Since dedifferentiated and anaplastic thyroid carcinomas do not take...
Autores principales: | Broecker-Preuss, Martina, Becher-Boveleth, Nina, Gall, Susanne, Rehmann, Katrin, Schenke, Susann, Mann, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603293/ https://www.ncbi.nlm.nih.gov/pubmed/26464561 http://dx.doi.org/10.1186/s12935-015-0251-8 |
Ejemplares similares
-
Indirubin Derivative 7-Bromoindirubin-3-Oxime (7Bio) Attenuates Aβ Oligomer-Induced Cognitive Impairments in Mice
por: Chen, Liping, et al.
Publicado: (2017) -
The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells
por: Broecker-Preuss, Martina, et al.
Publicado: (2016) -
The Indirubin Derivative 6-Bromoindirubin-3′-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects
por: Tsakiri, Eleni N., et al.
Publicado: (2017) -
6-Bromoindirubin-3’-oxime (6BIO) prevents myocardium from aging by inducing autophagy
por: Guo, Donghao, et al.
Publicado: (2020) -
BIO (6-bromoindirubin-3′-oxime) GSK3 inhibitor induces dopaminergic differentiation of human immortalized RenVm cells
por: Soleimani, Mitra, et al.
Publicado: (2018)